Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand.
Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand.
Sci Rep. 2021 May 13;11(1):10173. doi: 10.1038/s41598-021-89700-8.
To provide a contemporary global prevalence of mental health issues among the general population amid the coronavirus disease-2019 (COVID-19) pandemic. We searched electronic databases, preprint databases, grey literature, and unpublished studies from January 1, 2020, to June 16, 2020 (updated on July 11, 2020), with no language restrictions. Observational studies using validated measurement tools and reporting data on mental health issues among the general population were screened to identify all relevant studies. We have included information from 32 different countries and 398,771 participants. The pooled prevalence of mental health issues amid the COVID-19 pandemic varied widely across countries and regions and was higher than previous reports before the COVID-19 outbreak began. The global prevalence estimate was 28.0% for depression; 26.9% for anxiety; 24.1% for post-traumatic stress symptoms; 36.5% for stress; 50.0% for psychological distress; and 27.6% for sleep problems. Data are limited for other aspects of mental health issues. Our findings highlight the disparities between countries in terms of the poverty impacts of COVID-19, preparedness of countries to respond, and economic vulnerabilities that impact the prevalence of mental health problems. Research on the social and economic burden is needed to better manage mental health problems during and after epidemics or pandemics. Systematic review registration: PROSPERO CRD 42020177120.
提供 2019 年冠状病毒病(COVID-19)大流行期间普通人群中心理健康问题的当代全球流行情况。我们搜索了电子数据库、预印本数据库、灰色文献和未发表的研究,检索时间为 2020 年 1 月 1 日至 2020 年 6 月 16 日(于 2020 年 7 月 11 日更新),无语言限制。使用经过验证的测量工具进行的观察性研究,并报告普通人群中心理健康问题的数据,筛选出所有相关研究。我们纳入了来自 32 个不同国家和 398771 名参与者的信息。COVID-19 大流行期间心理健康问题的综合患病率在各国和各地区差异很大,高于 COVID-19 爆发前的先前报告。全球患病率估计为:抑郁症 28.0%;焦虑症 26.9%;创伤后应激症状 24.1%;压力 36.5%;心理困扰 50.0%;睡眠问题 27.6%。其他方面的心理健康问题数据有限。我们的研究结果强调了各国在 COVID-19 贫困影响、国家应对准备和影响心理健康问题流行的经济脆弱性方面的差异。需要对社会和经济负担进行研究,以便在流行病或大流行期间和之后更好地管理心理健康问题。系统评价注册:PROSPERO CRD42020177120。